Validic, a provider of data solutions for remote monitoring and virtual engagement is integrating with Welldoc’s BlueStar platform. The integration of personal health data within the Welldoc BlueStar digital therapeutic platform will allow users to connect their wearables, apps, and in-home health devices directly to the platform – enabling deeper engagement and better self-management of one's health.The Power of Leveraging Device-Generated Data for PatientsAs the number of people managing
Read More
WellDoc BlueStar
Providence Health & Services Launches Digital Therapeutic Pilot Program for Individuals with Type 2 Diabetes
WellDoc announced a pilot program with Providence Health & Services to examine the use of WellDoc’s BlueStar, an FDA-cleared, proven digital therapeutic for individuals with type 2 diabetes. Providence Health & Services has utilized the power and innovation of mobile technology into clinical practice before and is now carrying it into the diabetes management arena.The pilot program will take place in the Providence Health & Services Oregon/SW Washington Region. It will include
Read More
WellDoc’s Digital Platform for Type 2 Diabetes Powers “Diabetes Wellness Program” Through Samsung Health
Samsung Electronics America, Inc. and WellDoc, a digital therapeutic company, announced today that Samsung Health users now have access to a new consumer version of WellDoc’s digital platform known as the Diabetes Wellness Program (DWP). Samsung Health users now have access to a new Diabetes Wellness Program (DWP) available through the Samsung Health service that is powered by WellDoc’s platform used in its BlueStar® product. It is available to individuals in the United States with Samsung
Read More
Solera Health Integrates WellDoc’s BlueStar Digital Therapeutic for Diabetes Management
Solera Health, an integrated benefit network, and WellDoc, a leading digital therapeutic company has announced that WellDoc’s BlueStar® digital therapeutic will join the Solera network as a diabetes management solution of choice. The integration partnership aligns both companies’ goals to improve the lives of those living with chronic diseases while enhancing clinical results and decreasing overall healthcare costs.Solera Health connects patients, payers and physicians with community
Read More
WellDoc, AADE Jointly Launch The Diabetes Digital Health Learning Network
WellDoc, a digital health company revolutionizing chronic disease management to help transform lives has announced the launch of ‘The Diabetes Digital Health Learning Network’ in collaboration with the American Association of Diabetes Educators (AADE). The Learning Network will support its members who are on the front lines of diabetes care and management by assisting diabetes educators in gaining next-generation skills in using digital health therapeutics to improve clinical care and outcomes
Read More
Samsung Health Integrates with WellDoc’s Consumer Diabetes Health App
Today, WellDoc announced it has entered a joint commercial partnership agreement with Samsung. The enhanced partnership with WellDoc gives Samsung an opportunity to serve global consumers who are ready to embrace the combined health innovations that both companies plan to offer. Samsung also becomes a distribution channel for WellDoc.The companies will integrate WellDoc’s newly-released consumer diabetes health app, BlueStar® C, with the recently launched Samsung Health, a mobile one-stop shop
Read More
WellDoc, American Association of Diabetes Educators Partner on Digital Diabetes Content
WellDoc and the American Association of Diabetes Educators (AADE) has partnered to integrate its “AADE Diabetes Education Curriculum: A Guide to Successful Self-Management” into WellDoc's BlueStar digital therapeutic platform. BlueStar is an FDA-cleared digital therapeutic used to help adults living with type 2 diabetes self-manage their condition. Additionally, both parties will explore how to collectively engage AADE’s members, as well as develop new strategies that bring innovative tools to
Read More
FDA Clears Wireless Integration of LifeScan’s OneTouch With WellDoc’s Diabetes Management Platform
The U.S. Food and Drug Administration (FDA) announced it has cleared the wireless integration of the OneTouch Verio Flex® blood glucose monitoring system with WellDoc Inc.'s clinically validated diabetes management platform, BlueStar®. The integration will create an integrated, connected experience for people with Type 2 diabetes and deliver value for healthcare providers. Integration DetailsUsing blood glucose data wirelessly and automatically transmitted from the OneTouch Verio Flex blood
Read More